{"id":"W2168372454","doi":"10.1200/jco.2014.56.9590","title":"Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; GlaxoSmithKline","keywords":"Lapatinib; Medicine; Trastuzumab; Taxane; Internal medicine; Metastatic breast cancer; Oncology; Hazard ratio; Breast cancer; Docetaxel; Clinical endpoint; Pertuzumab; Cancer; Clinical trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005175475,0.000293522,0.002657166,0.0002261367,0.00007847189,0.00001265096,0.0004710148,0.0005803033,0.0005187051],"category_scores_gemma":[0.009260351,0.0001957493,0.0006668935,0.0002989958,0.0005606575,0.0001993212,0.00007393187,0.001599405,0.00001191243],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001283081,"about_ca_system_score_gemma":0.01279132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003220692,"about_ca_topic_score_gemma":0.0002705607,"domain_scores_codex":[0.993162,0.0008637575,0.003901636,0.0004280357,0.001023551,0.0006209902],"domain_scores_gemma":[0.987318,0.004954372,0.003130516,0.0003196298,0.003260794,0.001016635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.3210934,0.003299223,0.01108087,0.0001965277,0.0009435716,0.0004598638,0.00111802,0.00004823882,0.003423689,0.00007210546,0.06657383,0.5916907],"study_design_scores_gemma":[0.2108025,0.2143836,0.3630828,0.001400708,0.0005110627,0.001541853,0.001430198,0.0002143532,0.010291,0.0006419319,0.1950026,0.0006974149],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9701577,0.000698577,0.0002165528,0.02322808,0.001927047,0.001298897,0.0008620872,0.00001995906,0.0015911],"genre_scores_gemma":[0.9844148,0.001860997,0.006523249,0.001588212,0.003740166,0.00007237039,0.00003109227,0.00006282827,0.001706334],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5909932,"threshold_uncertainty_score":0.9990851,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3663924786049742,"score_gpt":0.5653644802031109,"score_spread":0.1989720015981367,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}